Status and phase
Conditions
Treatments
About
This is a prospective, single-arm, open-label phase II study of Chidamide in combination with R-CHOP in the treatment of de novo, elderly, high-risk diffuse large B cell lymphoma patients.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
49 participants in 1 patient group
Loading...
Central trial contact
Pengpeng Xu, MD; Weili Zhao, MD,PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal